- Comprar cripto
- Mercados
- Futuros
- Spot
- Copy trading
WE-Launch
US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
AI News Today: Cuando la IA se encuentra con la blockchain, oportunidades que no puedes perderte
Ethereum Dips Below $2900
SOL Short-Term Price Drops Below $130
Powell Resignation Rumor Surfacing Again? Will Deliver Speech Tuesday Morning
A certain whale went 10x long on HYPE, with a position value exceeding $19 million, and a liquidation price of $25.724
Atención al cliente：@weikecs
Cooperación empresarial：@weikecs
Trading cuantitativo y MM：[email protected]
Programa VIP：[email protected]
App